Oridonin induces apoptosis and senescence of colorectal cancer SW1116 cells in vitro and in vivo

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 30, Issue 6, 2010, Pages 683-688

  Gao, Feng Hou ^a   Guo, Zhu Ying ^a   Xu, Mang Hua ^a   Wang, Shi Ting ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Colorectal cancer; Growth arrest; Oridonin; Senescence

Indexed keywords

BETA GALACTOSIDASE; CHOLECYSTOKININ OCTAPEPTIDE; ORIDONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; COLONY FORMATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 77955974999     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kemp Z, Thirlwell C, Sieber O, et al. An update on the genetics of colorectal cancer[J]. Hum Mol Genet, 2004, 13(2): R177-R185.
2. Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer[J]. World J Gastroenterol, 2003,9(2): 193-200.
3. Zhou GB, Kang H, Wang L, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo[J]. Blood, 2007, 109(8): 3441-3450.
4. Zhou GB, Chen SJ, Wang ZY, et al. Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo[J]. Cell Res, 2007, 17(4): 274-276.
5. Zhang Y, Wu Y, Tashiro S, et al. Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis[J]. Biochem Biophys Res Commun, 2009, 378 (2): 273-278.
6. Hu HZ, Yang YB, Xu XD, et al. Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line[J]. Acta Pharmacol Sin, 2007, 28(11): 1819-1826.
7. Li D, Wu LJ, Tashiro S, et al. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway[J]. J Asian Nat Prod Res, 2008, 10(1-2): 77-87.
8. Cui Q, Yu JH, Wu JN, et al. T. Ikejima, P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells[J]. Acta Pharmacol Sin, 2007, 28(7): 1057-1066.
9. Zhu Y, Xie L, Chen G, et al. Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice[J]. Pharmazie, 2007, 62(6): 439-444. (Pubitemid 46975266)
10. Liu JJ, Huang RW, Lin DJ, et al. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action[J]. Am J Hematol, 2006, 81(2): 86-94.